Correlation Between Swedish Orphan and Vitrolife
Can any of the company-specific risk be diversified away by investing in both Swedish Orphan and Vitrolife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swedish Orphan and Vitrolife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swedish Orphan Biovitrum and Vitrolife AB, you can compare the effects of market volatilities on Swedish Orphan and Vitrolife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swedish Orphan with a short position of Vitrolife. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swedish Orphan and Vitrolife.
Diversification Opportunities for Swedish Orphan and Vitrolife
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Swedish and Vitrolife is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Swedish Orphan Biovitrum and Vitrolife AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitrolife AB and Swedish Orphan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swedish Orphan Biovitrum are associated (or correlated) with Vitrolife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitrolife AB has no effect on the direction of Swedish Orphan i.e., Swedish Orphan and Vitrolife go up and down completely randomly.
Pair Corralation between Swedish Orphan and Vitrolife
Assuming the 90 days trading horizon Swedish Orphan Biovitrum is expected to generate 0.65 times more return on investment than Vitrolife. However, Swedish Orphan Biovitrum is 1.53 times less risky than Vitrolife. It trades about 0.06 of its potential returns per unit of risk. Vitrolife AB is currently generating about 0.04 per unit of risk. If you would invest 24,020 in Swedish Orphan Biovitrum on September 4, 2024 and sell it today you would earn a total of 6,400 from holding Swedish Orphan Biovitrum or generate 26.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Swedish Orphan Biovitrum vs. Vitrolife AB
Performance |
| Timeline |
| Swedish Orphan Biovitrum |
| Vitrolife AB |
Swedish Orphan and Vitrolife Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Swedish Orphan and Vitrolife
The main advantage of trading using opposite Swedish Orphan and Vitrolife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swedish Orphan position performs unexpectedly, Vitrolife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitrolife will offset losses from the drop in Vitrolife's long position.| Swedish Orphan vs. Getinge AB ser | Swedish Orphan vs. Elekta AB | Swedish Orphan vs. AB SKF | Swedish Orphan vs. Saab AB |
| Vitrolife vs. BioInvent International AB | Vitrolife vs. Alligator Bioscience AB | Vitrolife vs. Swedish Orphan Biovitrum | Vitrolife vs. Anoto Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |